Wolfe C L, Sievers R E, Visseren F L, Donnelly T J
Cardiovascular Research Institute, University of California, San Francisco 94143-0124.
Circulation. 1993 Mar;87(3):881-92. doi: 10.1161/01.cir.87.3.881.
Although previous investigators have demonstrated that myocardial preconditioning reduces infarct size, the mechanisms of cardioprotection associated with preconditioning are not completely understood.
To test the hypothesis that preconditioning (four 5-minute episodes of ischemia each followed by 5 minutes of reperfusion) reduces infarct size by depleting cardiac glycogen stores and attenuating the degree of intracellular acidosis during subsequent prolonged left coronary artery occlusion, preconditioned and control rats were subjected to 45 minutes of left coronary artery occlusion and 120 minutes of reflow immediately after preconditioning (groups 1P and 1C, respectively) or after 30 minutes (groups 2P+30m and 2C), 1 hour (groups 3P+60m and 3C), or 6 hours (groups 4P+360m and 4C) of nonischemic recovery after preconditioning but before prolonged ischemia. In each group, cardiectomy was performed in selected rats immediately before prolonged ischemia for cardiac glycogen assay. In selected animals, 31P magnetic resonance spectroscopy was performed to monitor intracellular pH and measure high-energy phosphate levels during ischemia and reperfusion. Group 1P rats demonstrated marked glycogen depletion after preconditioning compared with controls (0.72 +/- 0.39 [n = 9] versus 5.67 +/- 1.73 [n = 12] mg glucose/g wet wt; p < 0.001 versus group 1C) that was associated with attenuation of intracellular acidosis during ischemia, as measured by 31P magnetic resonance spectroscopy (6.8 +/- 0.3 [n = 11] versus 6.2 +/- 0.3 [n = 9] pH units; p < 0.01), and marked infarct size reduction (0.3 +/- 0.6% [n = 7] versus 38.1 +/- 11.3% [n = 7], infarct size divided by risk area; p < 0.0001). During ischemia, there were no differences in myocardial ATP or phosphocreatine levels or in any hemodynamic determinant of myocardial oxygen demand between groups 1P and 1C. In preconditioned rats that were allowed to recover before ischemia (groups 2P+30m, 3P+60m, and 4P+360m), the time course of glycogen repletion paralleled the loss of protection from ischemic injury.
Glycogen depletion and the attenuation of intracellular acidosis during ischemia appear to be important factors in delaying irreversible injury and reducing infarct size in this animal model of myocardial preconditioning.
尽管先前的研究人员已证明心肌预处理可减小梗死面积,但与预处理相关的心脏保护机制尚未完全明确。
为验证预处理(四次5分钟的缺血发作,每次之后再灌注5分钟)通过消耗心脏糖原储备并减轻随后长时间左冠状动脉闭塞期间细胞内酸中毒程度来减小梗死面积这一假说,将预处理组和对照组大鼠在预处理后立即(分别为1P组和1C组)或在预处理后但在长时间缺血前进行30分钟(2P + 30m组和2C组)、1小时(3P + 60m组和3C组)或6小时(4P + 360m组和4C组)的非缺血恢复后,进行45分钟的左冠状动脉闭塞和120分钟的再灌注。在每组中,在选定的大鼠长时间缺血前立即进行心脏切除以测定心脏糖原。在选定的动物中,在缺血和再灌注期间进行31P磁共振波谱分析以监测细胞内pH值并测量高能磷酸水平。与对照组相比,1P组大鼠在预处理后显示出明显的糖原消耗(0.72±0.39 [n = 9] 对5.67±1.73 [n = 12] mg葡萄糖/g湿重;与1C组相比p < 0.001),这与通过31P磁共振波谱分析测定的缺血期间细胞内酸中毒减轻相关(6.8±0.3 [n = 11] 对6.2±0.3 [n = 9] pH单位;p < 0.01),并且梗死面积明显减小(0.3±0.6% [n = 7] 对38.1±11.3% [n = 7],梗死面积除以危险区域;p < 0.0001)。在缺血期间,1P组和1C组之间心肌ATP或磷酸肌酸水平以及心肌氧需求的任何血流动力学决定因素均无差异。在缺血前允许恢复的预处理大鼠(2P + 30m组、3P + 60m组和4P + 360m组)中,糖原补充的时间进程与缺血性损伤保护作用的丧失平行。
在这个心肌预处理动物模型中,缺血期间糖原消耗和细胞内酸中毒减轻似乎是延迟不可逆损伤和减小梗死面积的重要因素。